281 related articles for article (PubMed ID: 17665027)
41. [Crow-Fukase syndrome and VEGF].
Arimura K; Hashiguchi T; Watanabe O
Brain Nerve; 2008 Jun; 60(6):611-9. PubMed ID: 18567356
[TBL] [Abstract][Full Text] [Related]
42. [POEMS syndrome: a review of the literature].
Méndez-Herrera CR; Cordoví-Rodríguez D
Rev Neurol; 2011 Jul; 53(1):44-50. PubMed ID: 21678324
[TBL] [Abstract][Full Text] [Related]
43. POEMS syndrome: definitions and long-term outcome.
Dispenzieri A; Kyle RA; Lacy MQ; Rajkumar SV; Therneau TM; Larson DR; Greipp PR; Witzig TE; Basu R; Suarez GA; Fonseca R; Lust JA; Gertz MA
Blood; 2003 Apr; 101(7):2496-506. PubMed ID: 12456500
[TBL] [Abstract][Full Text] [Related]
44. [Poems syndrome: a case report].
Tellería A; Hernández-González E; Gómez-Fernández L; Mustelier R; Calzada-Sierra D
Rev Neurol; 1997 Apr; 25(140):565-8. PubMed ID: 9172922
[TBL] [Abstract][Full Text] [Related]
45. [POEMS syndrome revealed by a scleroderma-like skin thickening].
Toussaint P; Sibaud V; Labbe L; Geniaux M
Ann Dermatol Venereol; 2000 Jan; 127(1):73-6. PubMed ID: 10717569
[TBL] [Abstract][Full Text] [Related]
46. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2011 Jul; 86(7):591-601. PubMed ID: 21681783
[TBL] [Abstract][Full Text] [Related]
47. [Crow-Fukase syndrome].
Hitoshi S
Nihon Rinsho; 1995 Mar; 53(3):747-51. PubMed ID: 7699917
[TBL] [Abstract][Full Text] [Related]
48. [46-year-old patient with polyneuropathy, hepatosplenomegaly, endocrinopathy, M-gradient, skin manifestations, sclerotic bone changes and therapy refractory ascites].
Siegel EG; Fölsch UR
Z Gastroenterol; 1999 Apr; 37(4):283-6. PubMed ID: 10378364
[TBL] [Abstract][Full Text] [Related]
49. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
50. Plasma cell dyscrasia with polyneuropathy--POEMS syndrome presenting with vasculitic skin lesions and responding to combination chemotherapy.
Sharabi Y; Raanani P; Shenkar A; Thaler M; Grossman E
Leuk Lymphoma; 2000 Dec; 40(1-2):209-13. PubMed ID: 11426623
[TBL] [Abstract][Full Text] [Related]
51. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2014 Feb; 89(2):214-23. PubMed ID: 24532337
[TBL] [Abstract][Full Text] [Related]
52. Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Associated With Castleman Disease: A Common Misdiagnosis.
Palha V; Condez E; Lopes V; Ferreira C; Mayor JS; Pimentel T; Oliveira N; Tavares M
J Med Cases; 2021 Oct; 12(10):400-404. PubMed ID: 34691336
[TBL] [Abstract][Full Text] [Related]
53. POEMS Syndrome: Therapeutic Options.
Jaccard A
Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
[TBL] [Abstract][Full Text] [Related]
54. Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin change (POEMS) syndrome with IgG kappa paraproteinemia.
Romas E; Storey E; Ayers M; Byrne E
Pathology; 1992 Jul; 24(3):217-20. PubMed ID: 1437299
[TBL] [Abstract][Full Text] [Related]
55. Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.
Paranavitane S; Gooneratne L; Chang T
J Med Case Rep; 2019 Dec; 13(1):384. PubMed ID: 31878962
[TBL] [Abstract][Full Text] [Related]
56. POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome in China.
Cui RT; Huang XS; Shi Q; Tian CL; Liu JX; Pu CQ
Intern Med J; 2011 Jun; 41(6):481-5. PubMed ID: 20059597
[TBL] [Abstract][Full Text] [Related]
57. Paraneoplastic Progressive Vasculopathy as the Presenting Manifestation of Polyneuropathy, Organomegaly, Endocrinopathy or Edema, M-Spike, and Skin Manifestations: A Case Report.
Yaghi S; Elkind MSV
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):e103-e107. PubMed ID: 27177922
[TBL] [Abstract][Full Text] [Related]
58. Proposal of new clinical diagnostic criteria for POEMS syndrome.
Suichi T; Misawa S; Sato Y; Beppu M; Sakaida E; Sekiguchi Y; Shibuya K; Watanabe K; Amino H; Kuwabara S
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):133-137. PubMed ID: 30279213
[TBL] [Abstract][Full Text] [Related]
59. POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.
Dispenzieri A
Am J Hematol; 2017 Aug; 92(8):814-829. PubMed ID: 28699668
[TBL] [Abstract][Full Text] [Related]
60. Clinical manifestation of POEMS syndrome with features of connective tissue disease.
Eidner T; Oelzner P; Ebhardt H; Kosmehl H; Stein G; Hein G
Clin Rheumatol; 2001; 20(1):70-2. PubMed ID: 11254247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
